RESUMEN
Objective To evaluate our ability in classifying the fetal heart as normal or abnormal during the 1st trimester scan through fetal cardiac examination and determining the best time for this examination. Methods This was a prospective study performed on 3240 pregnant women to examine the fetal heart. Four chambers view and ventricular outflow tracts were mainly examined during the scan. We used grayscale and color mapping in the diagnosis. Color Doppler was used if additional information was needed, and all patients were rescanned during the 2nd trimester to confirm or negate our diagnosis. Results The cardiac findings were normal at both scans in 3108 pregnancies. The same cardiac abnormality was detected at both scans in 79 cases. In 36 cases there was false-positive diagnosis at the early scan; in 20 of these cases, there were mildly abnormal functional findings early in pregnancy with no abnormality found later. In 17 fetuses, there was discordance between the early and later diagnosis due to missed or incorrect diagnoses. The best time to do fetal heart examination during 1st trimester is between 13 and 13 + 6 weeks. Conclusion A high degree of accuracy in the identification of congenital heart disease (CHD) can be achieved by a 1st trimester fetal echocardiography.
Asunto(s)
Cardiopatías Congénitas/diagnóstico por imagen , Primer Trimestre del Embarazo , Adolescente , Adulto , Femenino , Corazón Fetal/diagnóstico por imagen , Humanos , Embarazo , Estudios Prospectivos , Sensibilidad y Especificidad , Ultrasonografía Prenatal , Adulto JovenRESUMEN
Collecting strong enough and repeatable signals from laser-induced plasmas is the primary goal of laser-induced breakdown spectroscopy optical detection systems. Typically, the light emitted from the plasma is refracted by the lens, collected by the fiber, and measured by the spectrometer. In the present work, we established a three-dimensional model to systematically evaluate the overall emission collected from different positions of the plasma for a typical optical collection system composed of a focus lens and a collection fiber, and sensitivity analyses were further performed. In addition, experiments were conducted and partially validated the model. Results showed that for the collection system with an optical fiber located on the focal point of the collection lens, the collection efficiency distribution is almost constant within a large cylindrical-shaped area, while for that located off the focal point, there is a rhombus-shaped area with higher collection efficiency than other areas. This much higher collection efficiency area is small in size but has a large impact on the detected spectral intensity. The spatially distributed collection efficiency on the lens parameters, such as size and position, was further discussed to clarify the impacts of the collection system. Furthermore, sensitivity analyses were performed to evaluate the impact of the collection system on the signal repeatability. Based on these calculations, recommendations for the design of the collection for optimized spectral intensity and stability were proposed.
RESUMEN
BACKGROUND: There are few contemporary data on the mortality and morbidity associated with rheumatic heart disease or information on their predictors. We report the 2-year follow-up of individuals with rheumatic heart disease from 14 low- and middle-income countries in Africa and Asia. METHODS: Between January 2010 and November 2012, we enrolled 3343 patients from 25 centers in 14 countries and followed them for 2 years to assess mortality, congestive heart failure, stroke or transient ischemic attack, recurrent acute rheumatic fever, and infective endocarditis. RESULTS: Vital status at 24 months was known for 2960 (88.5%) patients. Two-thirds were female. Although patients were young (median age, 28 years; interquartile range, 18-40), the 2-year case fatality rate was high (500 deaths, 16.9%). Mortality rate was 116.3/1000 patient-years in the first year and 65.4/1000 patient-years in the second year. Median age at death was 28.7 years. Independent predictors of death were severe valve disease (hazard ratio [HR], 2.36; 95% confidence interval [CI], 1.80-3.11), congestive heart failure (HR, 2.16; 95% CI, 1.70-2.72), New York Heart Association functional class III/IV (HR, 1.67; 95% CI, 1.32-2.10), atrial fibrillation (HR, 1.40; 95% CI, 1.10-1.78), and older age (HR, 1.02; 95% CI, 1.01-1.02 per year increase) at enrollment. Postprimary education (HR, 0.67; 95% CI, 0.54-0.85) and female sex (HR, 0.65; 95% CI, 0.52-0.80) were associated with lower risk of death. Two hundred and four (6.9%) patients had new congestive heart failure (incidence, 38.42/1000 patient-years), 46 (1.6%) had a stroke or transient ischemic attack (8.45/1000 patient-years), 19 (0.6%) had recurrent acute rheumatic fever (3.49/1000 patient-years), and 20 (0.7%) had infective endocarditis (3.65/1000 patient-years). Previous stroke and older age were independent predictors of stroke/transient ischemic attack or systemic embolism. Patients from low- and lower-middle-income countries had significantly higher age- and sex-adjusted mortality than patients from upper-middle-income countries. Valve surgery was significantly more common in upper-middle-income than in lower-middle- or low-income countries. CONCLUSIONS: Patients with clinical rheumatic heart disease have high mortality and morbidity despite being young; those from low- and lower-middle-income countries had a poorer prognosis associated with advanced disease and low education. Programs focused on early detection and the treatment of clinical rheumatic heart disease are required to improve outcomes.
Asunto(s)
Endocarditis/mortalidad , Insuficiencia Cardíaca/mortalidad , Sistema de Registros , Cardiopatía Reumática/mortalidad , Accidente Cerebrovascular/mortalidad , Adolescente , Adulto , África/epidemiología , Factores de Edad , Asia/epidemiología , Países en Desarrollo , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana EdadRESUMEN
AIMS: Rheumatic heart disease (RHD) accounts for over a million premature deaths annually; however, there is little contemporary information on presentation, complications, and treatment. METHODS AND RESULTS: This prospective registry enrolled 3343 patients (median age 28 years, 66.2% female) presenting with RHD at 25 hospitals in 12 African countries, India, and Yemen between January 2010 and November 2012. The majority (63.9%) had moderate-to-severe multivalvular disease complicated by congestive heart failure (33.4%), pulmonary hypertension (28.8%), atrial fibrillation (AF) (21.8%), stroke (7.1%), infective endocarditis (4%), and major bleeding (2.7%). One-quarter of adults and 5.3% of children had decreased left ventricular (LV) systolic function; 23% of adults and 14.1% of children had dilated LVs. Fifty-five percent (n = 1761) of patients were on secondary antibiotic prophylaxis. Oral anti-coagulants were prescribed in 69.5% (n = 946) of patients with mechanical valves (n = 501), AF (n = 397), and high-risk mitral stenosis in sinus rhythm (n = 48). However, only 28.3% (n = 269) had a therapeutic international normalized ratio. Among 1825 women of childbearing age (12-51 years), only 3.6% (n = 65) were on contraception. The utilization of valvuloplasty and valve surgery was higher in upper-middle compared with lower-income countries. CONCLUSION: Rheumatic heart disease patients were young, predominantly female, and had high prevalence of major cardiovascular complications. There is suboptimal utilization of secondary antibiotic prophylaxis, oral anti-coagulation, and contraception, and variations in the use of percutaneous and surgical interventions by country income level.
Asunto(s)
Cardiopatía Reumática/terapia , Administración Oral , Adulto , Distribución por Edad , Antibacterianos/uso terapéutico , Profilaxis Antibiótica , Anticoagulantes/administración & dosificación , Estudios Transversales , Países en Desarrollo , Medicina Basada en la Evidencia , Femenino , Salud Global , Enfermedades de las Válvulas Cardíacas/epidemiología , Enfermedades de las Válvulas Cardíacas/etiología , Enfermedades de las Válvulas Cardíacas/terapia , Humanos , Masculino , Penicilinas/uso terapéutico , Proyectos Piloto , Estudios Prospectivos , Cardiopatía Reumática/complicaciones , Cardiopatía Reumática/epidemiología , Distribución por SexoRESUMEN
BACKGROUND: Cardiac dysfunction frequently complicates the clinical course of patients with end-stage renal failure (ESRF). Recently, we observed abnormal longitudinal cardiac rotation (LR) among patients with ESRF. In this study, we sought to quantify LR mechanics in patients undergoing hemodialysis (HD). METHODS: Twenty-four subjects, 12 ESRF patients (58% male; age 17.5 ± 4.4 years) receiving HD, and 12 aged-matched controls, were prospectively studied. Patients underwent echocardiographic studies before and after HD. LR mechanics were quantified with two-dimensional speckle tracking echocardiography. Peak systolic left ventricular (LV) longitudinal strain and displacement measurements were obtained in all subjects. RESULTS: LR mechanics were successfully quantified in all subjects using 5 key echocardiographic features of LR. We identified two different inhomogeneous LR motion patterns in 41.7% of ESRF patients, characterized by a delayed timing of LR or increased segmental apical rotation. Inhomogeneous LR patterns were not found in controls. Timing of early-systolic counterclockwise LR increased after HD (P = 0.006). In patients, late-systolic clockwise LR occurred earlier (P = 0.043), and showed a significant prolongation after HD (P = 0.003). Longitudinal strain was significantly impaired in patients (P = 0.015), and further decreased after HD (P < 0.0001). Strong correlations were observed between strain and displacement parameters and LR mechanics. CONCLUSIONS: Quantifying LR using speckle tracking echocardiography was feasible, easy, and reproducible. Inhomogeneous LR motion patterns were demonstrated in a large proportion of patients with ESRF. LV dysfunction seems the most important determinant of inhomogeneous LR. Further studies are required to validate these findings.
Asunto(s)
Ecocardiografía/métodos , Fallo Renal Crónico/complicaciones , Fallo Renal Crónico/terapia , Diálisis Renal/efectos adversos , Disfunción Ventricular Izquierda/diagnóstico por imagen , Disfunción Ventricular Izquierda/etiología , Adolescente , Módulo de Elasticidad , Diagnóstico por Imagen de Elasticidad/métodos , Femenino , Humanos , Interpretación de Imagen Asistida por Computador/métodos , Masculino , Reproducibilidad de los Resultados , Rotación , Sensibilidad y Especificidad , Resultado del Tratamiento , Disfunción Ventricular Izquierda/fisiopatologíaRESUMEN
OBJECTIVES: Percutaneous patent ductus arteriosus (PDA) stenting is a therapeutic modality in patients with duct-dependent pulmonary circulation with reported success rates from 80-100%. The current study aims to assess the outcome and the indicators of success for PDA stenting in different ductal morphologies using various approaches. METHODS: A prospective cohort study from a single tertiary center presented from January 2018 to December 2019 that included 96 consecutive infants with ductal-dependent pulmonary circulation and palliated with PDA stenting. Patients were divided according to PDA origin into 4 groups: Group 1: PDA from proximal descending aorta, Group 2: from undersurface of aortic arch, Group 3: opposite the subclavian artery, Group 4: opposite the innominate/brachiocephalic artery. RESULTS: The median age of patients was 22 days and median weight was 3 kg. The procedure was successful in 78 patients (81.25%). PDA was tortuous in 70 out of 96 patients. Femoral artery was the preferred approach in Group 1 (63/67), while axillary artery access was preferred in the other groups (6/11 in Group 2, 11/17 in Group 3, 1/1 in Group 4, P <0.0001). The main cause of procedural failure was inadequate parked coronary wire inside one of the branch of pulmonary arteries (14 cases; 77.7%), while 2 cases (11.1%) were complicated by acute stent thrombosis, and another 2 cases with stent dislodgment. Other procedural complications comprised femoral artery thrombosis in 7 cases (7.2%). Patients with straight PDA, younger age at procedure and who had larger PDA at pulmonary end had higher odds for success (OR = 8.01, 2.94, 7.40, CI = 1.011-63.68, 0.960-0.99, 1.172-7.40,respectively, P = 0.048, 0.031,0.022 respectively). CONCLUSIONS: The approach for PDA stenting and hence the outcome is markedly determined by the PDA origin and morphology. Patients with straight PDA, younger age at procedure and those who had relatively larger PDA at the pulmonary end had better opportunity for successful procedure.
Asunto(s)
Conducto Arterioso Permeable , Cateterismo Cardíaco/métodos , Conducto Arterioso Permeable/cirugía , Humanos , Lactante , Estudios Prospectivos , Circulación Pulmonar , Estudios Retrospectivos , Stents , Resultado del TratamientoRESUMEN
Developments in femtosecond laser induced breakdown spectroscopy (fs-LIBS) applications during the last two decades have further centered on innovative métier tie-in to the advantageous properties of femtosecond laser ablation (fs-LA) introduced into LIBS. Yet, for industrially-oriented application like coal analysis, no research has exposed to view the analytical capabilities of fs-LA in enhancing the physical processes of coal ablation and the impact into quantitative correlation of spectra and data modeling. In a huge coal market, fast and accurate analysis of coal property is eminently important for coal pricing, combustion optimization, and pollution reduction. Moreover, there is a thirst need of precision standardization for coal analyzers in use. In this letter, the analytical performance of a one-box femtosecond laser system is evaluated relative to an industrially applied coal analyzer based on five objectives/measures: spectral correlation, relative sensitivity factors, craters topology, plasma parameters, and repeatability. Despite high-threshold operation parameters of the fs system, competitive results are achieved compared to the optimized analytical conditions of the ns-coal analyzer. Studies targeting the in-field optimization of fs-LIBS systems for coal analysis can potentially provide insights into fs-plasma hydrodynamics under harsh conditions, instrumental customization, and pave the way for a competitive next-generation of coal analyzers.
RESUMEN
Repeatability is of utmost importance as it is directly linked to measurement accuracy and precision of a technique and affects its cost, utility, and commercialization. The present paper contributes to explain enhanced repeatability of the femtosecond laser-induced breakdown spectroscopy (fs-LIBS) technique, remarkably significant for its industrial applications and instrumental size reduction. A fs-laser with 7 mJ pulse energy was focused to create a transient titanium plasma, and a high-resolution spectrometer was used to study time-resolved spectra and single-shot drilling sampling repeatability. Time-resolved spectroscopy study at a delay time interval of 0-1600 ns showed 200-400 ns as the optimum delay time zone for data acquisition with 2-4% line intensity RSDs. Plasma temperature RSDs were <1.8% for the investigated delay interval and reached 0.5% at 200 ns where the temperature recorded a maximum value of 22,000 K. Electron density reached 5.7 × 1017 cm-3 at 200 ns, and RSDs were <3% with the least fluctuation of 0.7%. Shot-to-shot RSDs were 3.5-5% at 15-30 drilling shot intervals for line intensities, <2% for plasma temperature, and <6.5% for electron density. Using an uncertainty propagation formula, total number density RSDs were calculated to be 1.9-5.3% for 50 single-shot drilling scenarios. Considering physics behind results, fs-plasmas are "stable ablation sources" due to their electrostatic formation mechanisms and confined hydrodynamic evolution. The fs-laser opens up new directions for LIBS applications where accuracy is significantly enhanced.
RESUMEN
Acute rheumatic fever (ARF) and rheumatic heart disease (RHD) remain major causes of heart failure, stroke and death among African women and children, despite being preventable and imminently treatable. From 21 to 22 February 2015, the Social Cluster of the Africa Union Commission (AUC) hosted a consultation with RHD experts convened by the Pan-African Society of Cardiology (PASCAR) in Addis Ababa, Ethiopia, to develop a 'roadmap' of key actions that need to be taken by governments to eliminate ARF and eradicate RHD in Africa. Seven priority areas for action were adopted: (1) create prospective disease registers at sentinel sites in affected countries to measure disease burden and track progress towards the reduction of mortality by 25% by the year 2025, (2) ensure an adequate supply of high-quality benzathine penicillin for the primary and secondary prevention of ARF/RHD, (3) improve access to reproductive health services for women with RHD and other non-communicable diseases (NCD), (4) decentralise technical expertise and technology for diagnosing and managing ARF and RHD (including ultrasound of the heart), (5) establish national and regional centres of excellence for essential cardiac surgery for the treatment of affected patients and training of cardiovascular practitioners of the future, (6) initiate national multi-sectoral RHD programmes within NCD control programmes of affected countries, and (7) foster international partnerships with multinational organisations for resource mobilisation, monitoring and evaluation of the programme to end RHD in Africa. This Addis Ababa communiqué has since been endorsed by African Union heads of state, and plans are underway to implement the roadmap in order to end ARF and RHD in Africa in our lifetime.